Cleared Traditional

K123375 - SYNGO.VIA

K123375 is an FDA 510(k) clearance for SYNGO.VIA, manufactured by Siemens AG. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 19-day FDA review.

K123375 · Siemens AG · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
19d
Days
Class 2
Risk

K123375 is an FDA 510(k) clearance for the SYNGO.VIA. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Siemens AG (Erlangen, DE). The FDA issued a Cleared decision on November 20, 2012 after a review of 19 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K123375

510(k) Number K123375 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 2012
Decision Date November 20, 2012
Days to Decision 19 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 107d · This submission: 19d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Tuv Sud America, Inc.

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2231
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K123375.
MAMMOGRAPHY PRIOR ENHANCEMENT (MPE)
K123530 · Hologic, Inc. · Dec 2012
ERAD PACS/ERAD RIS/PACS/ERAD EPVLITE VIEWER SOFTWARE PRODUCT
K120995 · Erad, Inc. · Dec 2012
VESSEL ANALYSIS AND AUTOPLAQUE FOR ORS VISUAL
K122429 · Object Research Systems (Ors), Inc. · Nov 2012
STEREOS WORKSTATION
K113344 · Eos Imaging · Nov 2012
CENTRICITY PACS-IW WITH UNIVERSAL VIEWER
K123174 · Ge Healthcare · Nov 2012
FLIGHTPLAN FOR LIVER
K121200 · Ge Healthcare · Nov 2012